profit from every $100 of sales.
$0$100
iTonic Holdings
$2.01+8.65% today
+280.7% in 1 year
1-year low $0.271-year high $8.10
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What iTonic Holdings sold, what it kept, and what it did with the cash.
Sales went from $679,777 in 2022 to $523,031 in 2025, with -$5.10 million of profit last year.
SalesProfit
iTonic Holdings vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| iTonic Holdings | No profit yet | ||
 Ekso Bionics Holdings | No profit yet | ||
 Takara Bio | 130.1× · Very expensive | ||
 Shoulder Innovations | No profit yet | ||
 Mobia Medical | No profit yet |
AI analysis
An AI analyst reads iTonic Holdings's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 1 | 0 | 1 | |
| 1 | 0 | 0 | 0 | |
| 0 | -0 | -1 | -5 | |
| 0 | -0 | -1 | -5 | |
| 0 | -0 | -1 | -5 | |
| 0.01 | -0.02 | -0.05 | – | |
| 82.1% | 74.9% | 85.0% | 62.6% | |
| 11.0% | -41.1% | -147.7% | -987.5% | |
| 12.4% | -38.4% | -147.4% | -974.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1 | 2 | 7 | 9 |
| Cash | 0 | 0 | 6 | 1 |
| Total debt | 0 | 0 | 0 | 0 |
| Total liabilities | 1 | 1 | 1 | 1 |
| 1 | 0 | 6 | 6 | |
| 12 | 12 | 13 | – | |
| 7.6% | -44.2% | -8.1% | -65.1% | |
| 15.1% | -78.8% | -10.7% | -83.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -0 | -0 | -1 | -3 | |
| – | – | 0 | 0 | |
| -0 | -0 | -1 | -3 | |
| Dividends paid | 0 | 0 | 0 | 0 |
| – | – | – | – | |
| – | 0 | 0 | 3 |
Valuation
- –
- –
- –
- 1.0×
- 28.1×
- –
- –
- -22.0%
- -34.7%
- 0.0%
Profitability
- 62.6%
- -987.5%
- -974.7%
- -775.2%
- -52.1%
- -9.1%
- -44.2%
- -47.2%
- -53.6%
- 27.2%
Growth
- −8.4%
- –
- −1,119.1%
- –
- −4.3%
Financial health
- -0.3×
- 0.03
- 2.7%
- –
- 11.69
- 11.36
- 0.06
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 953
Bottom 8%of 871
Bottom 4%of 988
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
42No pass
Benjamin Graham
67Pass
Philip Fisher
58No pass
Peter Lynch
40No pass
Joel Greenblatt
0No pass
Charlie Munger
64Pass
Terry Smith
56No pass
Questions about iTonic Holdings
Is iTonic Holdings a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the iTonic Holdings AI analysis
What does iTonic Holdings do?
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. It is in Medical - Specialties.
Does iTonic Holdings pay a dividend?
No. iTonic Holdings does not pay a dividend at the moment.
Is iTonic Holdings stock halal?
Yes. iTonic Holdings passes our halal screen: its business is permitted and its debt is 1.0% of its market value, under the 30% limit. How we check
How has iTonic Holdings stock done over the past year?
Up 280.7% over the past twelve months, to $2.01. It traded between $0.27 and $8.10 and is 75.2% below its high.
Who are iTonic Holdings's competitors?
The largest listed companies in the same industry are Ekso Bionics Holdings, Takara Bio, Shoulder Innovations and Mobia Medical. The peers table on this page compares their profit, growth and price with iTonic Holdings's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.